40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.23%
Positive revenue growth while MTDR is negative. John Neff might see a notable competitive edge here.
-2.71%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-72.59%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-72.59%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-233.51%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-236.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-236.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-63.55%
Dividend reduction while MTDR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-50.59%
Negative OCF growth while MTDR is at 20.79%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-186.73%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-3.08%
Negative 10Y revenue/share CAGR while MTDR stands at 622.69%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-78.20%
Negative 5Y CAGR while MTDR stands at 622.69%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-0.83%
Negative 3Y CAGR while MTDR stands at 622.69%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
8.61%
10Y OCF/share CAGR under 50% of MTDR's 449.17%. Michael Burry would worry about a persistent underperformance in cash creation.
-77.02%
Negative 5Y OCF/share CAGR while MTDR is at 449.17%. Joel Greenblatt would question the firm’s operational model or cost structure.
-49.86%
Negative 3Y OCF/share CAGR while MTDR stands at 449.17%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-222.60%
Negative 10Y net income/share CAGR while MTDR is at 1053.61%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-123.68%
Negative 5Y net income/share CAGR while MTDR is 1053.61%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-496.00%
Negative 3Y CAGR while MTDR is 1053.61%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-21.02%
Negative equity/share CAGR over 10 years while MTDR stands at 24.72%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-77.23%
Negative 5Y equity/share growth while MTDR is at 24.72%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-70.38%
Negative 3Y equity/share growth while MTDR is at 24.72%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
637.70%
Stable or rising dividend while MTDR is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
-86.79%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-73.54%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
114.38%
AR growth well above MTDR's 4.39%. Michael Burry fears inflated revenue or higher default risk in the near future.
81.02%
Inventory growth well above MTDR's 14.26%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.00%
Negative asset growth while MTDR invests at 11.88%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-4.91%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.48%
We’re deleveraging while MTDR stands at 37.93%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
21.70%
SG&A growth well above MTDR's 22.95%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.